Reconsidering early HIV treatment and supervised treatment interruptions.
Koup
Richard A
RA
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rkoup@mail.nih.gov
D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology* / Q000821:virology; D006801:Humans; D019562:Viral Load; D014766:Viremia; D014779:Virus Replication
D044966:Anti-Retroviral Agents